The University of Delaware is making major strides in the biopharma sector by launching the new SABRE Center. Backed by $45 million in federal funding, including $10 million from the American Rescue Plan, this 90,000-square-foot hub is set to propel the university into a leader in biopharmaceutical
Streamlining for Efficiency Reducing Workforce in Switzerland and the US In an ongoing effort to refine its operations, Novartis has announced a significant reduction in its workforce that will see between 400 and 440 jobs eliminated in Switzerland, specifically targeting operational and
